Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BVAIT: Vitamin B in Early Atherosclerosis
NCT00114400Phase 3Completed
- Sponsor
- National Institute on Aging
- Start
- Nov 2000
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of folic acid, vitamin b12 and pyridoxine in atherosclerosis (2 arms), sponsored by National Institute on Aging. Primary endpoint: Rate of change of distal common carotid artery (CCA) far wall intima-media thickness (IMT). Started Nov 2000; status: completed.
02
Drugs
folic acidvitamin b12pyridoxine
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00114400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114400.